Request for Covid-19 Impact Assessment of this Report
Sales, means the sales volume of Pain Management Drugs
Revenue, means the sales value of Pain Management Drugs
This report studies sales (consumption) of Pain Management Drugs in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering
AstraZeneca
Endo International
Johnson & Johnson
Pfizer
Purdue Pharma
Baxter
Bayer
GlaxoSmithKline
Merck
Novartis
Roche
Sanofi
Eli Lilly
Zynerba Pharmaceuticals
Market Segment by States, covering
California
Texas
New York
Florida
Illinois
Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into
Type I
Type II
Split by applications, this report focuses on sales, market share and growth rate of Pain Management Drugs in each application, can be divided into
Application 1
Application 2
United States Pain Management Drugs Market Report 2017
1 Pain Management Drugs Overview
1.1 Product Overview and Scope of Pain Management Drugs
1.2 Classification of Pain Management Drugs
1.2.1 Type I
1.2.2 Type II
1.3 Application of Pain Management Drugs
1.3.1 Application 1
1.3.2 Application 2
1.4 United States Market Size Sales (Volume) and Revenue (Value) of Pain Management Drugs (2012-2022)
1.4.1 United States Pain Management Drugs Sales and Growth Rate (2012-2022)
1.4.2 United States Pain Management Drugs Revenue and Growth Rate (2012-2022)
2 United States Pain Management Drugs Competition by Manufacturers
2.1 United States Pain Management Drugs Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 United States Pain Management Drugs Revenue and Share by Manufactures (2015 and 2016)
2.3 United States Pain Management Drugs Average Price by Manufactures (2015 and 2016)
2.4 Pain Management Drugs Market Competitive Situation and Trends
2.4.1 Pain Management Drugs Market Concentration Rate
2.4.2 Pain Management Drugs Market Share of Top 3 and Top 5 Manufacturers
2.4.3 Mergers & Acquisitions, Expansion
3 United States Pain Management Drugs Sales (Volume) and Revenue (Value) by States (2012-2017)
3.1 United States Pain Management Drugs Sales and Market Share by States (2012-2017)
3.2 United States Pain Management Drugs Revenue and Market Share by States (2012-2017)
3.3 United States Pain Management Drugs Price by States (2012-2017)
4 United States Pain Management Drugs Sales (Volume) and Revenue (Value) by Type (2012-2017)
4.1 United States Pain Management Drugs Sales and Market Share by Type (2012-2017)
4.2 United States Pain Management Drugs Revenue and Market Share by Type (2012-2017)
4.3 United States Pain Management Drugs Price by Type (2012-2017)
4.4 United States Pain Management Drugs Sales Growth Rate by Type (2012-2017)
5 United States Pain Management Drugs Sales (Volume) by Application (2012-2017)
5.1 United States Pain Management Drugs Sales and Market Share by Application (2012-2017)
5.2 United States Pain Management Drugs Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities
6 United States Pain Management Drugs Manufacturers Profiles/Analysis
6.1 AstraZeneca
6.1.1 Company Basic Information, Manufacturing Base and Competitors
6.1.2 Pain Management Drugs Product Type, Application and Specification
6.1.2.1 Product A
6.1.2.2 Product B
6.1.3 AstraZeneca Pain Management Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
6.1.4 Main Business/Business Overview
6.2 Endo International
6.2.2 Pain Management Drugs Product Type, Application and Specification
6.2.2.1 Product A
6.2.2.2 Product B
6.2.3 Endo International Pain Management Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
6.2.4 Main Business/Business Overview
6.3 Johnson & Johnson
6.3.2 Pain Management Drugs Product Type, Application and Specification
6.3.2.1 Product A
6.3.2.2 Product B
6.3.3 Johnson & Johnson Pain Management Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
6.3.4 Main Business/Business Overview
6.4 Pfizer
6.4.2 Pain Management Drugs Product Type, Application and Specification
6.4.2.1 Product A
6.4.2.2 Product B
6.4.3 Pfizer Pain Management Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
6.4.4 Main Business/Business Overview
6.5 Purdue Pharma
6.5.2 Pain Management Drugs Product Type, Application and Specification
6.5.2.1 Product A
6.5.2.2 Product B
6.5.3 Purdue Pharma Pain Management Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
6.5.4 Main Business/Business Overview
6.6 Baxter
6.6.2 Pain Management Drugs Product Type, Application and Specification
6.6.2.1 Product A
6.6.2.2 Product B
6.6.3 Baxter Pain Management Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
6.6.4 Main Business/Business Overview
6.7 Bayer
6.7.2 Pain Management Drugs Product Type, Application and Specification
6.7.2.1 Product A
6.7.2.2 Product B
6.7.3 Bayer Pain Management Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
6.7.4 Main Business/Business Overview
6.8 GlaxoSmithKline
6.8.2 Pain Management Drugs Product Type, Application and Specification
6.8.2.1 Product A
6.8.2.2 Product B
6.8.3 GlaxoSmithKline Pain Management Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
6.8.4 Main Business/Business Overview
6.9 Merck
6.9.2 Pain Management Drugs Product Type, Application and Specification
6.9.2.1 Product A
6.9.2.2 Product B
6.9.3 Merck Pain Management Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
6.9.4 Main Business/Business Overview
6.10 Novartis
6.10.2 Pain Management Drugs Product Type, Application and Specification
6.10.2.1 Product A
6.10.2.2 Product B
6.10.3 Novartis Pain Management Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
6.10.4 Main Business/Business Overview
6.11 Roche
6.12 Sanofi
6.13 Eli Lilly
6.14 Zynerba Pharmaceuticals
7 Pain Management Drugs Manufacturing Cost Analysis
7.1 Pain Management Drugs Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Price Trend of Key Raw Materials
7.1.3 Key Suppliers of Raw Materials
7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.2.1 Raw Materials
7.2.2 Labor Cost
7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Pain Management Drugs
8 Industrial Chain, Sourcing Strategy and Downstream Buyers
8.1 Pain Management Drugs Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Pain Management Drugs Major Manufacturers in 2015
8.4 Downstream Buyers
9 Marketing Strategy Analysis, Distributors/Traders
9.1 Marketing Channel
9.1.1 Direct Marketing
9.1.2 Indirect Marketing
9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
9.2.1 Pricing Strategy
9.2.2 Brand Strategy
9.2.3 Target Client
9.3 Distributors/Traders List
10 Market Effect Factors Analysis
10.1 Technology Progress/Risk
10.1.1 Substitutes Threat
10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change
11 United States Pain Management Drugs Market Forecast (2017-2022)
11.1 United States Pain Management Drugs Sales, Revenue Forecast (2017-2022)
11.2 United States Pain Management Drugs Sales Forecast by Type (2017-2022)
11.3 United States Pain Management Drugs Sales Forecast by Application (2017-2022)
11.4 Pain Management Drugs Price Forecast (2017-2022)
12 Research Findings and Conclusion
13 Appendix
Methodology
Analyst Introduction
Data Source
Figure Picture of Pain Management Drugs
Table Classification of Pain Management Drugs
Figure United States Sales Market Share of Pain Management Drugs by Type in 2015
Table Application of Pain Management Drugs
Figure United States Sales Market Share of Pain Management Drugs by Application in 2015
Figure United States Pain Management Drugs Sales and Growth Rate (2012-2022)
Figure United States Pain Management Drugs Revenue and Growth Rate (2012-2022)
Table United States Pain Management Drugs Sales of Key Manufacturers (2015 and 2016)
Table United States Pain Management Drugs Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Pain Management Drugs Sales Share by Manufacturers
Figure 2016 Pain Management Drugs Sales Share by Manufacturers
Table United States Pain Management Drugs Revenue by Manufacturers (2015 and 2016)
Table United States Pain Management Drugs Revenue Share by Manufacturers (2015 and 2016)
Table 2015 United States Pain Management Drugs Revenue Share by Manufacturers
Table 2016 United States Pain Management Drugs Revenue Share by Manufacturers
Table United States Market Pain Management Drugs Average Price of Key Manufacturers (2015 and 2016)
Figure United States Market Pain Management Drugs Average Price of Key Manufacturers in 2015
Figure Pain Management Drugs Market Share of Top 3 Manufacturers
Figure Pain Management Drugs Market Share of Top 5 Manufacturers
Table United States Pain Management Drugs Sales by States (2012-2017)
Table United States Pain Management Drugs Sales Share by States (2012-2017)
Figure United States Pain Management Drugs Sales Market Share by States in 2015
Table United States Pain Management Drugs Revenue and Market Share by States (2012-2017)
Table United States Pain Management Drugs Revenue Share by States (2012-2017)
Figure Revenue Market Share of Pain Management Drugs by States (2012-2017)
Table United States Pain Management Drugs Price by States (2012-2017)
Table United States Pain Management Drugs Sales by Type (2012-2017)
Table United States Pain Management Drugs Sales Share by Type (2012-2017)
Figure United States Pain Management Drugs Sales Market Share by Type in 2015
Table United States Pain Management Drugs Revenue and Market Share by Type (2012-2017)
Table United States Pain Management Drugs Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Pain Management Drugs by Type (2012-2017)
Table United States Pain Management Drugs Price by Type (2012-2017)
Figure United States Pain Management Drugs Sales Growth Rate by Type (2012-2017)
Table United States Pain Management Drugs Sales by Application (2012-2017)
Table United States Pain Management Drugs Sales Market Share by Application (2012-2017)
Figure United States Pain Management Drugs Sales Market Share by Application in 2015
Table United States Pain Management Drugs Sales Growth Rate by Application (2012-2017)
Figure United States Pain Management Drugs Sales Growth Rate by Application (2012-2017)
Table AstraZeneca Basic Information List
Table AstraZeneca Pain Management Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Figure AstraZeneca Pain Management Drugs Sales Market Share (2012-2017)
Table Endo International Basic Information List
Table Endo International Pain Management Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Table Endo International Pain Management Drugs Sales Market Share (2012-2017)
Table Johnson & Johnson Basic Information List
Table Johnson & Johnson Pain Management Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Table Johnson & Johnson Pain Management Drugs Sales Market Share (2012-2017)
Table Pfizer Basic Information List
Table Pfizer Pain Management Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Table Pfizer Pain Management Drugs Sales Market Share (2012-2017)
Table Purdue Pharma Basic Information List
Table Purdue Pharma Pain Management Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Table Purdue Pharma Pain Management Drugs Sales Market Share (2012-2017)
Table Baxter Basic Information List
Table Baxter Pain Management Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Table Baxter Pain Management Drugs Sales Market Share (2012-2017)
Table Bayer Basic Information List
Table Bayer Pain Management Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Table Bayer Pain Management Drugs Sales Market Share (2012-2017)
Table GlaxoSmithKline Basic Information List
Table GlaxoSmithKline Pain Management Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Table GlaxoSmithKline Pain Management Drugs Sales Market Share (2012-2017)
Table Merck Basic Information List
Table Merck Pain Management Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Table Merck Pain Management Drugs Sales Market Share (2012-2017)
Table Novartis Basic Information List
Table Novartis Pain Management Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Table Novartis Pain Management Drugs Sales Market Share (2012-2017)
Table Roche Basic Information List
Table Sanofi Basic Information List
Table Eli Lilly Basic Information List
Table Zynerba Pharmaceuticals Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Pain Management Drugs
Figure Manufacturing Process Analysis of Pain Management Drugs
Figure Pain Management Drugs Industrial Chain Analysis
Table Raw Materials Sources of Pain Management Drugs Major Manufacturers in 2015
Table Major Buyers of Pain Management Drugs
Table Distributors/Traders List
Figure United States Pain Management Drugs Production and Growth Rate Forecast (2017-2022)
Figure United States Pain Management Drugs Revenue and Growth Rate Forecast (2017-2022)
Table United States Pain Management Drugs Production Forecast by Type (2017-2022)
Table United States Pain Management Drugs Consumption Forecast by Application (2017-2022)
Table United States Pain Management Drugs Sales Forecast by States (2017-2022)
Table United States Pain Management Drugs Sales Share Forecast by States (2017-2022)
Proteins that are designed and engineered in the laboratory for pharmaceutical interventions to treat different diseases are known as protein therapeutics. The global protein therapeutics market accounted for $140,109 million in 2016, and is anticipated to rea...
Umbilical cord blood bank is storage facility that collects cord blood after the childbirth from placenta. Cord blood is rich source of stem cell used in treatment of different chronic diseases. Private and public cord blood banks are the two major types of banks that are prevalent in th...
The pharmaceutical agents that are administered to treat, diagnose, and prevent life-threatening diseases (rare diseases) are known as orphan drugs. The global orphan drugs market accounted for $106 billion in 2015, and is anticipated to reach $169 billio...